"The most aggressive type (breast cancer) is triple-negative breast cancer (TNBC) (...) [23].TNBC accounts for 10–20% of all breast cancers, and has a very poor prognosis, with chemotherapy the main therapeutic option [23, 24]." #AI https://t.co/D2Eg560fl
A framework for validating AI in precision medicine: considerations from the European ITFoC consortium https://t.co/IG162zq4oA
When using AI in healthcare, validation of the AI algorithm is probably the most important element in the process. @RosyTsopra et al. evaluated the European ITFoC consortium framework for triple-negative breast cancer. #healthcare #innovation https://t.co/
A framework for validating AI in precision medicine https://t.co/oQDB21LmZ8 https://t.co/OYSUqW3OeS